Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Intracranial tuberculomas developing while on therapy for pulmonary tuberculosis.

Deborah J Nicolls1, Mark King, David Holland

  • 1Division of Infectious Diseases, Emory University School of Medicine, Atlanta, Georgia, USA. dnicoll@emory.edu

The Lancet. Infectious Diseases
|November 29, 2005
PubMed
Summary

Intracranial tuberculomas can paradoxically develop or worsen during tuberculosis treatment, potentially due to an enhanced immune response. Corticosteroids are recommended for symptomatic cases, while treatment typically remains unchanged.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Short-Term Action for America's Health: Health Care, Public Health, and Community Collaboration to Reduce the Burden of Respiratory Infections, Opioid Use Disorder, and Other Public Health Threats.

NAM perspectives·2025
Same author

The Urgent Case for Recommitting to Global HIV/AIDS Goals.

JAMA·2024
Same author

Antiretroviral Drugs for Treatment and Prevention of HIV in Adults: 2024 Recommendations of the International Antiviral Society-USA Panel.

JAMA·2024
Same author

Mobilising the health community to protect health care from attack.

Lancet (London, England)·2024
Same author

The Impact of Stigma and Sexual Identity on PrEP Awareness and Use Among At-Risk Men Who Have Sex With Men in Four U.S. Cities (HPTN 078).

Stigma and health·2024
Same author

Psychosocial Factors Linked to Uncontrolled Infection and Mortality among People Living with HIV Who Use Substances: A Latent Class Analysis.

AIDS and behavior·2024

Area of Science:

  • Neurology
  • Infectious Diseases
  • Immunology

Background:

  • Tuberculosis (TB) is a global health challenge, primarily affecting the lungs but capable of disseminating to the central nervous system.
  • Intracranial tuberculomas, focal lesions caused by Mycobacterium tuberculosis in the brain, pose significant diagnostic and therapeutic challenges.
  • Paradoxical worsening or development of intracranial tuberculomas during antituberculous therapy (ATT) is a recognized but not fully understood phenomenon.

Observation:

  • This case report details a South Asian man who developed symptomatic intracranial tuberculomas while undergoing standard ATT for pulmonary tuberculosis.
  • The patient's neurological symptoms emerged despite appropriate and consistent antituberculous treatment.
  • This observation aligns with previous reports of paradoxical reactions in TB management.

Related Experiment Videos

Findings:

  • The development or progression of intracranial tuberculomas during ATT suggests a complex host-pathogen interaction, possibly an enhanced immune response.
  • Neuroimaging is crucial for diagnosing intracranial tuberculomas in patients with new neurological deficits during TB treatment.
  • Stereotactic brain biopsy is indicated when the diagnosis remains uncertain after initial investigations.

Implications:

  • While the exact etiology is unknown, the phenomenon highlights the need for vigilance regarding neurological complications in TB patients.
  • Routine brain imaging is not advised for all TB patients, but neuroimaging is essential for those with neurological symptoms.
  • Management of symptomatic intracranial tuberculomas typically involves continuing ATT and initiating corticosteroids, without altering the primary antituberculous regimen.